Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The potential of solanezumab and gantenerumab to prevent Alzheimer's disease in people with inherited mutations that cause its early onset.
Panza F, Seripa D, Lozupone M, Solfrizzi V, Imbimbo BP, Barulli MR, Tortelli R, Capozzo R, Bisceglia P, Dimitri A, Stallone R, Dibello V, Quaranta N, Daniele A, Bellomo A, Greco A, Logroscino G. Panza F, et al. Among authors: bisceglia p. Expert Opin Biol Ther. 2018 Jan;18(1):25-35. doi: 10.1080/14712598.2018.1389885. Epub 2017 Oct 16. Expert Opin Biol Ther. 2018. PMID: 29037101 Review.
Emerging drugs to reduce abnormal β-amyloid protein in Alzheimer's disease patients.
Panza F, Seripa D, Solfrizzi V, Imbimbo BP, Lozupone M, Leo A, Sardone R, Gagliardi G, Lofano L, Creanza BC, Bisceglia P, Daniele A, Bellomo A, Greco A, Logroscino G. Panza F, et al. Among authors: bisceglia p. Expert Opin Emerg Drugs. 2016 Dec;21(4):377-391. doi: 10.1080/14728214.2016.1241232. Epub 2016 Oct 6. Expert Opin Emerg Drugs. 2016. PMID: 27678025 Review.
Pharmacogenetics of neurological and psychiatric diseases at older age: has the time come?
Lozupone M, Panza F, Stella E, La Montagna M, Bisceglia P, Miscio G, Galizia I, Daniele A, di Mauro L, Bellomo A, Logroscino G, Greco A, Seripa D. Lozupone M, et al. Among authors: bisceglia p. Expert Opin Drug Metab Toxicol. 2017 Mar;13(3):259-277. doi: 10.1080/17425255.2017.1246533. Epub 2016 Oct 20. Expert Opin Drug Metab Toxicol. 2017. PMID: 27718745 Review.
Role of CLU, PICALM, and TNK1 Genotypes in Aging With and Without Alzheimer's Disease.
Seripa D, Panza F, Paroni G, D'Onofrio G, Bisceglia P, Gravina C, Urbano M, Lozupone M, Solfrizzi V, Bizzarro A, Boccardi V, Piccininni C, Daniele A, Logroscino G, Mecocci P, Masullo C, Greco A. Seripa D, et al. Among authors: bisceglia p. Mol Neurobiol. 2018 May;55(5):4333-4344. doi: 10.1007/s12035-017-0547-x. Epub 2017 Jun 19. Mol Neurobiol. 2018. PMID: 28631188
Innovative biomarkers in psychiatric disorders: a major clinical challenge in psychiatry.
Lozupone M, Seripa D, Stella E, La Montagna M, Solfrizzi V, Quaranta N, Veneziani F, Cester A, Sardone R, Bonfiglio C, Giannelli G, Bisceglia P, Bringiotti R, Daniele A, Greco A, Bellomo A, Logroscino G, Panza F. Lozupone M, et al. Among authors: bisceglia p. Expert Rev Proteomics. 2017 Sep;14(9):809-824. doi: 10.1080/14789450.2017.1375857. Epub 2017 Sep 11. Expert Rev Proteomics. 2017. PMID: 28870126 Review.
Psychotropic drugs and CYP2D6 in late-life psychiatric and neurological disorders. What do we know?
Seripa D, Lozupone M, Stella E, Paroni G, Bisceglia P, La Montagna M, D'onofrio G, Gravina C, Urbano M, Priore MG, Lamanna A, Daniele A, Bellomo A, Logroscino G, Greco A, Panza F. Seripa D, et al. Among authors: bisceglia p. Expert Opin Drug Saf. 2017 Dec;16(12):1373-1385. doi: 10.1080/14740338.2017.1389891. Epub 2017 Oct 12. Expert Opin Drug Saf. 2017. PMID: 29025271 Review.
Pharmacogenetics in the clinical analysis laboratory: clinical practice, research, and drug development pipeline.
Miscio G, Paroni G, Bisceglia P, Gravina C, Urbano M, Lozupone M, Piccininni C, Prisciandaro M, Ciavarella G, Daniele A, Bellomo A, Panza F, Di Mauro L, Greco A, Seripa D. Miscio G, et al. Among authors: bisceglia p. Expert Opin Drug Metab Toxicol. 2019 Sep;15(9):751-765. doi: 10.1080/17425255.2019.1658742. Epub 2019 Sep 12. Expert Opin Drug Metab Toxicol. 2019. PMID: 31512953 Review.
Are apolipoprotein E fragments a promising new therapeutic target for Alzheimer's disease?
Vecchio FL, Bisceglia P, Imbimbo BP, Lozupone M, Latino RR, Resta E, Leone M, Solfrizzi V, Greco A, Daniele A, Watling M, Panza F, Seripa D. Vecchio FL, et al. Among authors: bisceglia p. Ther Adv Chronic Dis. 2022 Mar 17;13:20406223221081605. doi: 10.1177/20406223221081605. eCollection 2022. Ther Adv Chronic Dis. 2022. PMID: 35321401 Free PMC article. Review.
16 results